7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Royalty Pharma plc
(NASDAQ:RPRX) 

RPRX stock logo

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the compa...

Founded: 1996
CEO: Pablo Gerardo Legorreta  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Royalty Pharma plc Days Payable Outstanding ttm (DPO)
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0125.32250.64375.95501.27626.59751.91877.22
Royalty Pharma plc Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 017.1734.3351.568.6685.83102.99120.16
Royalty Pharma plc Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.961.912.873.834.795.746.7
Royalty Pharma plc Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.891.772.663.554.445.326.21
Royalty Pharma plc Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.112.233.344.455.576.687.8
Royalty Pharma plc P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.222.453.674.96.127.358.57
Royalty Pharma plc (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -120.37-43.8132.74109.3185.86262.42338.98415.54
Royalty Pharma plc P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.450.891.341.792.242.683.13
No extra charts and metrics for this ticker.